Critical reviews in oncology/hematology
Mar 13, 2025
The convergence of artificial intelligence (AI) and nanomedicine has revolutionized the design of smart multifunctional nanocarriers (SMNs) for drug and gene delivery, offering unprecedented precision, efficiency, and personalization in therapeutic a...
Critical reviews in oncology/hematology
Mar 8, 2025
Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide. Despite advances in screening and treatment, CRC is heterogeneous and the response to therapy varies significantly, limiting personalized treatment options. Cer...
Critical reviews in oncology/hematology
Mar 1, 2025
Brain tumors refer to the abnormal growths that occur within the brain's tissue, comprising both primary neoplasms and metastatic lesions. Timely detection, precise staging, suitable treatment, and standardized management are of significant clinical ...
Critical reviews in oncology/hematology
Feb 7, 2025
Prostate cancer is one of the major health challenges in the world and needs novel therapeutic approaches to overcome the limitations of conventional treatment. This review delineates the transformative potential of artificial intelligence (AL) in en...
Critical reviews in oncology/hematology
Oct 15, 2024
Cancer, characterized by the uncontrolled division of abnormal cells that harm body tissues, necessitates early detection for effective treatment. Medical imaging is crucial for identifying various cancers, yet its manual interpretation by radiologis...
Critical reviews in oncology/hematology
Sep 2, 2024
Artificial intelligence (AI) has made a tremendous impact in the space of healthcare, and proton therapy is not an exception. Proton therapy has witnessed growing popularity in oncology over recent decades, and researchers are increasingly looking to...
Critical reviews in oncology/hematology
Aug 14, 2024
Radiomics, analysing quantitative features from medical imaging, has rapidly become an emerging field in translational oncology. Radiomics has been investigated in several neoplastic malignancies as it might allow for a non-invasive tumour characteri...
Critical reviews in oncology/hematology
Sep 21, 2022
Radiomics and deep learning (DL) hold transformative promise and substantial and significant advances in oncology; however, most methods have been tested in retrospective or simulated settings. There is considerable interest in the biomarker validati...
Critical reviews in oncology/hematology
Sep 7, 2022
Machine Learning (ML) represents a computer science capable of generating predictive models, by exposure to raw, training data, without being rigidly programmed. Over the last few years, ML has gained attention within the field of oncology, with cons...
Critical reviews in oncology/hematology
Jan 19, 2022
Bladder cancer (BCa) is the most common malignancy of the urinary tract and the most expensive malignancy to treat over the patients' lifetime. In recent years a number of studies have utilized Artificial Intelligence (AI) algorithms to perform certa...